Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
Introduction: Rectal neuroendocrine tumour (rNET) is prone to metastasis, and distant metastasis is associated with worse prognosis. However, factors influencing the prognosis of metastatic rNET and the recommended treatments remain controversial.
Conference:
Presenting Author: Yang Y
Authors: Yang Y, Chen L, Liu M, Jiang Y, Lin Y,
Keywords: metastatic rectal neuroendocrine tumour, liver metastasis, trans arterial embolisation, inverse probability of treatment weighting, overall survival,
Introduction: Complete resection is the cornerstone of curative-intent treatment for gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs) without distant metastases. However, there is a paucity of data on the impact of recent advancements in minimally invasive surgery (MIS), such as the utilization of laparoscopic and robotic approaches, on GEP-NEC patients’ outcomes.
Conference:
Presenting Author: Chen Q
Authors: Chen Q, Rhodin K, Li K, Kanu E, Zani S,
Keywords: Gastroenteropancreatic neuroendocrine carcinoma, Minimally Invasive Surgery, Open resection, Laparoscopic resection, Robotic resection, Outcome,
Introduction: The incidence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) is increasing globally, and the patients are often diagnosed with synchronous liver metastases. Despite recommendations for primary tumor resection (PTR) with or without liver resection (LR) in the patients, there are conflicting data for their impact on overall survival (OS).
Conference:
Presenting Author: Chen Q
Authors: Chen Q, Li K, Rhodin K, Bartholomew A, Lidsky M,
Keywords: Gastroenteropancreatic neuroendocrine tumor, Liver metastasis, Resection, Prognosis, National Cancer Database,
Introduction: The role of primary tumor resection (PTR) in the survival of gastrointestinal neuroendocrine carcinoma (GI-NEC) patients with liver metastases only remains poorly defined.
Conference:
Presenting Author: Chen Q
Authors: Chen Q, Li K, Rhodin K, Masoud S, Lidsky M,
Keywords: gastrointestinal neuroendocrine carcinoma, liver metastasis, primary tumor resection, national cancer database,
Our website automatically sets cookies, which are technically necessary for the operation of the website. By clicking "OK", Google Analytics and the associated cookies are also activated for the purpose of website analysis and optimization. Detailed Information and the possibility to revoke your consent at any time, you can find in our privacy policy.
These cookies are so-called "session cookies." They are automatically deleted after your visit.
Protects you from Cross-Site-Request-Forgery attacks.
Saves the current PHP session.
For webinar purposes, ENETS uses VIMEO as an embedded iframe on MY ENETS. VIMEO implements its own tracking system, which is beyond the of ENETS responsibility. By watching ENETS videos on the ENETS website, you also agree to the conditions of VIMEO: https://vimeo.com/privacy
This website uses Google Analytics, a web analytics service. It is operated by Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA. Google Analytics cookies are stored based on your consent Art. 6 (1) (a) DSGVO/GDPR, which we confirm via the consent banner.
For more information about how Google Analytics handles user data, see Google's privacy policy: https://support.google.com/analytics/answer/6004245?hl=en.